Trial Profile
Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (greater than 4 cm) - T4 N0-3 M0 or Any T N2-3 M0
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil (Primary) ; Mitomycin (Primary)
- Indications Anal cancer; Squamous cell cancer
- Focus Adverse reactions
- 27 Feb 2020 Status changed from active, no longer recruiting to completed.
- 26 Aug 2019 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
- 26 Aug 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Jan 2020.